Rank | Gene Set | Z-score |
---|---|---|
1 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 7.38637092 |
2 | presynaptic membrane assembly (GO:0097105) | 6.88960385 |
3 | sarcoplasmic reticulum calcium ion transport (GO:0070296) | 6.49962202 |
4 | glutamate secretion (GO:0014047) | 6.46572061 |
5 | vocalization behavior (GO:0071625) | 6.25400223 |
6 | presynaptic membrane organization (GO:0097090) | 6.14977127 |
7 | synaptic vesicle exocytosis (GO:0016079) | 6.11573758 |
8 | neurotransmitter-gated ion channel clustering (GO:0072578) | 6.05767357 |
9 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 6.05252731 |
10 | postsynaptic membrane organization (GO:0001941) | 5.89189591 |
11 | protein localization to synapse (GO:0035418) | 5.84414631 |
12 | * regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 5.83737275 |
13 | neuron cell-cell adhesion (GO:0007158) | 5.83658358 |
14 | muscle filament sliding (GO:0030049) | 5.82488991 |
15 | actin-myosin filament sliding (GO:0033275) | 5.82488991 |
16 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 5.58948740 |
17 | regulation of synaptic vesicle exocytosis (GO:2000300) | 5.57505189 |
18 | regulation of skeletal muscle contraction (GO:0014819) | 5.37250557 |
19 | * regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 5.34628837 |
20 | * regulation of glutamate receptor signaling pathway (GO:1900449) | 5.18088617 |
21 | regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880) | 5.13036782 |
22 | skeletal muscle contraction (GO:0003009) | 5.05146338 |
23 | positive regulation of potassium ion transmembrane transporter activity (GO:1901018) | 5.03014906 |
24 | neuronal action potential propagation (GO:0019227) | 4.98187176 |
25 | locomotory exploration behavior (GO:0035641) | 4.95169128 |
26 | synaptic vesicle maturation (GO:0016188) | 4.89202862 |
27 | positive regulation of synapse maturation (GO:0090129) | 4.88070060 |
28 | regulation of synaptic vesicle transport (GO:1902803) | 4.85586324 |
29 | cerebellar granule cell differentiation (GO:0021707) | 4.76185793 |
30 | actin-mediated cell contraction (GO:0070252) | 4.65797994 |
31 | regulation of relaxation of muscle (GO:1901077) | 4.65656367 |
32 | negative regulation of synaptic transmission, GABAergic (GO:0032229) | 4.63268210 |
33 | positive regulation of neurotransmitter secretion (GO:0001956) | 4.53815724 |
34 | regulation of ventricular cardiac muscle cell membrane repolarization (GO:0060307) | 4.49925081 |
35 | regulation of cardiac muscle contraction by calcium ion signaling (GO:0010882) | 4.46999827 |
36 | gamma-aminobutyric acid signaling pathway (GO:0007214) | 4.43016563 |
37 | regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion (GO | 4.41396832 |
38 | neuron-neuron synaptic transmission (GO:0007270) | 4.39402663 |
39 | striated muscle contraction (GO:0006941) | 4.35849412 |
40 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 4.35027001 |
41 | neurotransmitter secretion (GO:0007269) | 4.28664368 |
42 | synaptic transmission, glutamatergic (GO:0035249) | 4.27997680 |
43 | response to histamine (GO:0034776) | 4.27746432 |
44 | glutamate receptor signaling pathway (GO:0007215) | 4.22373974 |
45 | positive regulation of calcium ion transmembrane transporter activity (GO:1901021) | 4.20167458 |
46 | long-term synaptic potentiation (GO:0060291) | 4.17438678 |
47 | positive regulation of membrane potential (GO:0045838) | 4.14593248 |
48 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 4.14393381 |
49 | regulation of synapse maturation (GO:0090128) | 4.08488924 |
50 | * myofibril assembly (GO:0030239) | 4.03543997 |
51 | regulation of calcium ion transmembrane transport (GO:1903169) | 4.03091119 |
52 | regulation of calcium ion transmembrane transporter activity (GO:1901019) | 4.03091119 |
53 | * regulation of excitatory postsynaptic membrane potential (GO:0060079) | 4.01879155 |
54 | regulation of ryanodine-sensitive calcium-release channel activity (GO:0060314) | 3.98745932 |
55 | mechanosensory behavior (GO:0007638) | 3.97596939 |
56 | exploration behavior (GO:0035640) | 3.96319557 |
57 | positive regulation of phosphoprotein phosphatase activity (GO:0032516) | 3.89949046 |
58 | * regulation of postsynaptic membrane potential (GO:0060078) | 3.87914111 |
59 | sodium ion export (GO:0071436) | 3.87287556 |
60 | regulation of long-term neuronal synaptic plasticity (GO:0048169) | 3.82022291 |
61 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 3.81112474 |
62 | cardiac muscle contraction (GO:0060048) | 3.80719927 |
63 | regulation of inhibitory postsynaptic membrane potential (GO:0060080) | 3.80339358 |
64 | regulation of actin filament-based movement (GO:1903115) | 3.79406615 |
65 | cellular potassium ion homeostasis (GO:0030007) | 3.78688648 |
66 | positive regulation of neurotransmitter transport (GO:0051590) | 3.76003862 |
67 | negative regulation of dendrite morphogenesis (GO:0050774) | 3.75830695 |
68 | response to inactivity (GO:0014854) | 3.71640599 |
69 | negative regulation of potassium ion transmembrane transporter activity (GO:1901017) | 3.65986979 |
70 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 3.63431593 |
71 | * regulation of neurotransmitter secretion (GO:0046928) | 3.63431577 |
72 | regulation of membrane repolarization (GO:0060306) | 3.59627780 |
73 | auditory behavior (GO:0031223) | 3.59366896 |
74 | regulation of neuronal synaptic plasticity (GO:0048168) | 3.57671305 |
75 | nerve growth factor signaling pathway (GO:0038180) | 3.57638485 |
76 | response to stimulus involved in regulation of muscle adaptation (GO:0014874) | 3.57576994 |
77 | actin filament-based movement (GO:0030048) | 3.56398379 |
78 | regulation of synapse structural plasticity (GO:0051823) | 3.56222272 |
79 | positive regulation of synaptic transmission, glutamatergic (GO:0051968) | 3.55996492 |
80 | membrane assembly (GO:0071709) | 3.53354533 |
81 | G-protein coupled acetylcholine receptor signaling pathway (GO:0007213) | 3.52024092 |
82 | * regulation of synaptic plasticity (GO:0048167) | 3.51446773 |
83 | regulation of dendritic spine morphogenesis (GO:0061001) | 3.49904999 |
84 | startle response (GO:0001964) | 3.49146995 |
85 | skeletal muscle fiber development (GO:0048741) | 3.47823319 |
86 | gamma-aminobutyric acid transport (GO:0015812) | 3.47687507 |
87 | negative regulation of dendrite development (GO:2000171) | 3.47226429 |
88 | * regulation of synaptic transmission, glutamatergic (GO:0051966) | 3.47153594 |
89 | G-protein coupled glutamate receptor signaling pathway (GO:0007216) | 3.44582861 |
90 | positive regulation of potassium ion transmembrane transport (GO:1901381) | 3.40168425 |
91 | regulation of voltage-gated calcium channel activity (GO:1901385) | 3.37539569 |
92 | muscle cell cellular homeostasis (GO:0046716) | 3.37084792 |
93 | positive regulation of synapse assembly (GO:0051965) | 3.36327461 |
94 | neuron recognition (GO:0008038) | 3.34736008 |
95 | long-term memory (GO:0007616) | 3.34384654 |
96 | myotube cell development (GO:0014904) | 3.28917670 |
97 | regulation of striated muscle contraction (GO:0006942) | 3.28493573 |
98 | synaptic vesicle endocytosis (GO:0048488) | 3.28089158 |
99 | positive regulation of synaptic transmission (GO:0050806) | 3.27153626 |
100 | regulation of cardiac muscle cell contraction (GO:0086004) | 3.26813282 |
101 | * cardiac myofibril assembly (GO:0055003) | 3.26809222 |
102 | regulation of cell communication by electrical coupling (GO:0010649) | 3.24564375 |
103 | neurotransmitter transport (GO:0006836) | 3.21651502 |
104 | behavioral response to cocaine (GO:0048148) | 3.18661250 |
105 | activation of protein kinase A activity (GO:0034199) | 3.18135579 |
106 | negative regulation of potassium ion transmembrane transport (GO:1901380) | 3.17766465 |
107 | plasma membrane repair (GO:0001778) | 3.17393093 |
108 | cerebellar Purkinje cell differentiation (GO:0021702) | 3.17242604 |
109 | * membrane depolarization (GO:0051899) | 3.16807558 |
110 | potassium ion import (GO:0010107) | 3.15787627 |
111 | positive regulation of dendritic spine morphogenesis (GO:0061003) | 3.13626019 |
112 | central nervous system projection neuron axonogenesis (GO:0021952) | 3.13415580 |
113 | * regulation of neurotransmitter transport (GO:0051588) | 3.13351830 |
114 | positive regulation of cation channel activity (GO:2001259) | 3.13169942 |
115 | vesicle docking involved in exocytosis (GO:0006904) | 3.12968343 |
116 | positive regulation of ryanodine-sensitive calcium-release channel activity (GO:0060316) | 3.12442692 |
117 | sarcomere organization (GO:0045214) | 3.12171749 |
118 | layer formation in cerebral cortex (GO:0021819) | 3.10283940 |
119 | neuromuscular synaptic transmission (GO:0007274) | 3.09824623 |
120 | regulation of respiratory gaseous exchange by neurological system process (GO:0002087) | 3.09570946 |
121 | negative regulation of calcium ion transmembrane transporter activity (GO:1901020) | 3.09333713 |
122 | negative regulation of calcium ion transmembrane transport (GO:1903170) | 3.09333713 |
123 | vesicle docking (GO:0048278) | 3.09286538 |
124 | detection of calcium ion (GO:0005513) | 3.09091132 |
125 | regulation of potassium ion transmembrane transporter activity (GO:1901016) | 3.08822393 |
126 | transferrin transport (GO:0033572) | 3.02838080 |
127 | positive regulation of potassium ion transport (GO:0043268) | 3.02623443 |
128 | cell communication by electrical coupling (GO:0010644) | 3.01856596 |
129 | learning (GO:0007612) | 3.01837318 |
130 | positive regulation of dendritic spine development (GO:0060999) | 3.01741752 |
131 | synapse assembly (GO:0007416) | 3.01684511 |
132 | proline transport (GO:0015824) | 3.01305350 |
133 | synaptic transmission (GO:0007268) | 3.00752607 |
134 | axonal fasciculation (GO:0007413) | 2.99924614 |
135 | regulation of vesicle fusion (GO:0031338) | 2.99335159 |
136 | regulation of neurotransmitter levels (GO:0001505) | 2.98721942 |
137 | cell communication involved in cardiac conduction (GO:0086065) | 2.98252687 |
138 | response to auditory stimulus (GO:0010996) | 2.98087097 |
139 | positive regulation of myotube differentiation (GO:0010831) | 2.96537615 |
140 | * regulation of dendritic spine development (GO:0060998) | 2.95595582 |
141 | response to muscle activity (GO:0014850) | 2.93740230 |
142 | * regulation of synaptic transmission (GO:0050804) | 2.92733543 |
143 | regulation of atrial cardiac muscle cell membrane depolarization (GO:0060371) | 2.92160497 |
144 | regulation of respiratory system process (GO:0044065) | 2.91366503 |
145 | regulation of cation channel activity (GO:2001257) | 2.90958090 |
146 | relaxation of cardiac muscle (GO:0055119) | 2.90346905 |
147 | fear response (GO:0042596) | 2.89211730 |
148 | cochlea development (GO:0090102) | 2.89137023 |
149 | membrane depolarization during action potential (GO:0086010) | 2.88648168 |
150 | inositol phosphate catabolic process (GO:0071545) | 2.87312667 |
151 | long term synaptic depression (GO:0060292) | 2.87073170 |
152 | serotonin metabolic process (GO:0042428) | 2.85958626 |
153 | membrane hyperpolarization (GO:0060081) | 2.85723537 |
154 | establishment of synaptic vesicle localization (GO:0097480) | 2.85314655 |
155 | synaptic vesicle transport (GO:0048489) | 2.85314655 |
156 | ATP hydrolysis coupled proton transport (GO:0015991) | 2.85045593 |
Rank | Gene Set | Z-score |
---|---|---|
1 | EZH2_22144423_ChIP-Seq_EOC_Human | 5.75009821 |
2 | GBX2_23144817_ChIP-Seq_PC3_Human | 5.02657611 |
3 | * SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 3.07098580 |
4 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 2.87698043 |
5 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 2.85613276 |
6 | * TAF15_26573619_Chip-Seq_HEK293_Human | 2.74946793 |
7 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 2.57202404 |
8 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 2.50981033 |
9 | REST_21632747_ChIP-Seq_MESCs_Mouse | 2.47609926 |
10 | * CTBP2_25329375_ChIP-Seq_LNCAP_Human | 2.34269012 |
11 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 2.34113676 |
12 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 2.33862686 |
13 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 2.31163295 |
14 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 2.30741912 |
15 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 2.30045328 |
16 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 2.30045328 |
17 | * SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 2.25027091 |
18 | * ZFP57_27257070_Chip-Seq_ESCs_Mouse | 2.22034715 |
19 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 2.19605286 |
20 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 2.18876986 |
21 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 2.18600429 |
22 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 2.15014097 |
23 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 2.13340617 |
24 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 2.12487153 |
25 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 2.08199390 |
26 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 2.08109374 |
27 | DROSHA_22980978_ChIP-Seq_HELA_Human | 2.06252642 |
28 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 2.05870929 |
29 | GATA1_22025678_ChIP-Seq_K562_Human | 2.04295030 |
30 | AR_21572438_ChIP-Seq_LNCaP_Human | 2.00961777 |
31 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 2.00738265 |
32 | P300_19829295_ChIP-Seq_ESCs_Human | 1.99846916 |
33 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 1.99782721 |
34 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.98101155 |
35 | * POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.92123660 |
36 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.87438060 |
37 | * FUS_26573619_Chip-Seq_HEK293_Human | 1.85177869 |
38 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.85003715 |
39 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.84785554 |
40 | * EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.75417609 |
41 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.72781359 |
42 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.67232399 |
43 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.60995198 |
44 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.58599956 |
45 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 1.58584274 |
46 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.57881125 |
47 | AR_25329375_ChIP-Seq_VCAP_Human | 1.55374149 |
48 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.53965834 |
49 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 1.52462690 |
50 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.50528486 |
51 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.49235186 |
52 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.48150277 |
53 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.37305341 |
54 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 1.36791037 |
55 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.36561077 |
56 | * TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.36346549 |
57 | STAT3_23295773_ChIP-Seq_U87_Human | 1.35004806 |
58 | TCF4_23295773_ChIP-Seq_U87_Human | 1.34572048 |
59 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.33358261 |
60 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.33009803 |
61 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.32631342 |
62 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 1.31869467 |
63 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.31762227 |
64 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.30048372 |
65 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.29791755 |
66 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 1.28726805 |
67 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.28163439 |
68 | VDR_22108803_ChIP-Seq_LS180_Human | 1.26718146 |
69 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.25709572 |
70 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.25514611 |
71 | RNF2_27304074_Chip-Seq_NSC_Mouse | 1.24800723 |
72 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.24793254 |
73 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 1.24183764 |
74 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 1.23646360 |
75 | * AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.22827014 |
76 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.22819143 |
77 | TP53_16413492_ChIP-PET_HCT116_Human | 1.22386818 |
78 | TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 1.21254435 |
79 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.21138883 |
80 | * MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.18669393 |
81 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.18345487 |
82 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.17883817 |
83 | E2F1_18555785_Chip-Seq_ESCs_Mouse | 1.15128096 |
84 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 1.14736992 |
85 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.14393318 |
86 | TP53_18474530_ChIP-ChIP_U2OS_Human | 1.14322203 |
87 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.12400692 |
88 | * ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.12287163 |
89 | LMO2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.11493890 |
90 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.10606980 |
91 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.10606980 |
92 | JUN_21703547_ChIP-Seq_K562_Human | 1.10475633 |
93 | * SOX9_26525672_Chip-Seq_HEART_Mouse | 1.10456875 |
94 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.10360228 |
95 | P53_22387025_ChIP-Seq_ESCs_Mouse | 1.09569940 |
96 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.09518274 |
97 | * SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.08981913 |
98 | * AR_19668381_ChIP-Seq_PC3_Human | 1.07884839 |
99 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.07470728 |
100 | CEBPB_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.07183826 |
101 | * YAP1_20516196_ChIP-Seq_MESCs_Mouse | 1.07177774 |
102 | EWS_26573619_Chip-Seq_HEK293_Human | 1.06712849 |
103 | RUNX2_22187159_ChIP-Seq_PCA_Human | 1.05489850 |
104 | * FLI1_21867929_ChIP-Seq_TH2_Mouse | 1.05357236 |
105 | * TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.04589286 |
106 | * POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 1.04589286 |
107 | MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 1.04470056 |
108 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 1.04202617 |
109 | CBP_20019798_ChIP-Seq_JUKART_Human | 1.04181488 |
110 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 1.04181488 |
111 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 1.02398189 |
112 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.02017974 |
113 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 1.01938015 |
114 | MYC_20876797_ChIP-ChIP_MEDULLOBLASTOMA_Human | 1.01868430 |
115 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.01607654 |
116 | KDM2B_26808549_Chip-Seq_REH_Human | 1.01107506 |
117 | CMYC_18555785_Chip-Seq_ESCs_Mouse | 1.00530179 |
118 | RXR_22108803_ChIP-Seq_LS180_Human | 0.98495842 |
119 | * TAL1_21186366_ChIP-Seq_BM-HSCs_Mouse | 0.97800877 |
120 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.96013845 |
121 | FOXP2_21765815_ChIP-ChIP_NEURO2A_Mouse | 0.95594891 |
122 | VDR_24787735_ChIP-Seq_THP-1_Human | 0.95369635 |
123 | SUZ12_18555785_Chip-Seq_ESCs_Mouse | 0.94791088 |
124 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 0.91893861 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0004859_abnormal_synaptic_plasticity | 5.90533346 |
2 | MP0003880_abnormal_central_pattern | 5.58050281 |
3 | MP0003635_abnormal_synaptic_transmissio | 4.10247726 |
4 | MP0004270_analgesia | 3.86399449 |
5 | MP0001968_abnormal_touch/_nociception | 3.60747117 |
6 | MP0009745_abnormal_behavioral_response | 3.59679103 |
7 | MP0002063_abnormal_learning/memory/cond | 3.36792736 |
8 | MP0009046_muscle_twitch | 3.29669055 |
9 | MP0002064_seizures | 3.25786505 |
10 | MP0002572_abnormal_emotion/affect_behav | 2.91917798 |
11 | MP0002736_abnormal_nociception_after | 2.87050292 |
12 | MP0009780_abnormal_chondrocyte_physiolo | 2.80253933 |
13 | MP0002734_abnormal_mechanical_nocicepti | 2.57075261 |
14 | MP0003879_abnormal_hair_cell | 2.44176893 |
15 | MP0002272_abnormal_nervous_system | 2.37411166 |
16 | MP0001486_abnormal_startle_reflex | 2.36846287 |
17 | MP0005423_abnormal_somatic_nervous | 2.27836077 |
18 | MP0002067_abnormal_sensory_capabilities | 2.21010684 |
19 | MP0002735_abnormal_chemical_nociception | 2.20521789 |
20 | MP0003787_abnormal_imprinting | 2.14487031 |
21 | MP0001501_abnormal_sleep_pattern | 2.08440290 |
22 | MP0005646_abnormal_pituitary_gland | 2.02212296 |
23 | MP0004087_abnormal_muscle_fiber | 2.01408194 |
24 | * MP0000759_abnormal_skeletal_muscle | 2.00795804 |
25 | MP0001440_abnormal_grooming_behavior | 1.97893365 |
26 | MP0000751_myopathy | 1.83077139 |
27 | MP0001188_hyperpigmentation | 1.78787185 |
28 | MP0004145_abnormal_muscle_electrophysio | 1.77692687 |
29 | MP0005386_behavior/neurological_phenoty | 1.76341150 |
30 | MP0004924_abnormal_behavior | 1.76341150 |
31 | MP0008569_lethality_at_weaning | 1.74764401 |
32 | MP0002332_abnormal_exercise_endurance | 1.70250237 |
33 | MP0002733_abnormal_thermal_nociception | 1.66808727 |
34 | MP0002269_muscular_atrophy | 1.65932365 |
35 | MP0001970_abnormal_pain_threshold | 1.65237062 |
36 | MP0002557_abnormal_social/conspecific_i | 1.63990202 |
37 | MP0002837_dystrophic_cardiac_calcinosis | 1.62367953 |
38 | MP0004811_abnormal_neuron_physiology | 1.54539341 |
39 | MP0000778_abnormal_nervous_system | 1.53514061 |
40 | MP0002876_abnormal_thyroid_physiology | 1.44052851 |
41 | MP0001984_abnormal_olfaction | 1.41760540 |
42 | MP0002184_abnormal_innervation | 1.38746366 |
43 | MP0003633_abnormal_nervous_system | 1.38713561 |
44 | MP0000750_abnormal_muscle_regeneration | 1.35166668 |
45 | MP0004484_altered_response_of | 1.35114816 |
46 | MP0003045_fibrosis | 1.26452483 |
47 | * MP0002066_abnormal_motor_capabilities/c | 1.26006421 |
48 | MP0003950_abnormal_plasma_membrane | 1.24506064 |
49 | MP0004215_abnormal_myocardial_fiber | 1.23311167 |
50 | MP0002822_catalepsy | 1.21466499 |
51 | MP0003646_muscle_fatigue | 1.20563862 |
52 | MP0005330_cardiomyopathy | 1.18980626 |
53 | MP0000749_muscle_degeneration | 1.16661843 |
54 | MP0004036_abnormal_muscle_relaxation | 1.14516602 |
55 | MP0000733_abnormal_muscle_development | 1.13540402 |
56 | MP0002909_abnormal_adrenal_gland | 1.12983891 |
57 | MP0001905_abnormal_dopamine_level | 1.11113304 |
58 | MP0003183_abnormal_peptide_metabolism | 1.10121328 |
59 | MP0003631_nervous_system_phenotype | 1.08367323 |
60 | MP0002882_abnormal_neuron_morphology | 1.08021257 |
61 | MP0001502_abnormal_circadian_rhythm | 1.07722553 |
62 | MP0003828_pulmonary_edema | 1.07498037 |
63 | MP0004510_myositis | 1.06605358 |
64 | MP0000955_abnormal_spinal_cord | 1.06573081 |
65 | MP0004085_abnormal_heartbeat | 1.04990146 |
66 | MP0008874_decreased_physiological_sensi | 1.04105986 |
67 | MP0003137_abnormal_impulse_conducting | 1.02168758 |
68 | MP0000569_abnormal_digit_pigmentation | 1.01857946 |
69 | MP0005171_absent_coat_pigmentation | 1.00534188 |
70 | MP0003329_amyloid_beta_deposits | 0.99217751 |
71 | MP0006276_abnormal_autonomic_nervous | 0.98843808 |
72 | MP0003122_maternal_imprinting | 0.98297223 |
73 | MP0003303_peritoneal_inflammation | 0.96852127 |
74 | MP0004130_abnormal_muscle_cell | 0.95694668 |
75 | MP0008877_abnormal_DNA_methylation | 0.90742087 |
76 | MP0004142_abnormal_muscle_tone | 0.90324542 |
77 | MP0000013_abnormal_adipose_tissue | 0.89824269 |
78 | MP0001963_abnormal_hearing_physiology | 0.87589097 |
79 | MP0008004_abnormal_stomach_pH | 0.87336966 |
80 | MP0008872_abnormal_physiological_respon | 0.86846122 |
81 | MP0002152_abnormal_brain_morphology | 0.85838669 |
82 | MP0005167_abnormal_blood-brain_barrier | 0.84923606 |
83 | MP0001529_abnormal_vocalization | 0.84052718 |
84 | MP0005385_cardiovascular_system_phenoty | 0.83702190 |
85 | MP0001544_abnormal_cardiovascular_syste | 0.83702190 |
86 | MP0003690_abnormal_glial_cell | 0.80995985 |
87 | MP0001986_abnormal_taste_sensitivity | 0.80952826 |
88 | * MP0005620_abnormal_muscle_contractility | 0.80171611 |
89 | MP0004233_abnormal_muscle_weight | 0.79561434 |
90 | MP0000920_abnormal_myelination | 0.79183383 |
91 | MP0000015_abnormal_ear_pigmentation | 0.77066825 |
92 | MP0005084_abnormal_gallbladder_morpholo | 0.76736138 |
93 | MP0002108_abnormal_muscle_morphology | 0.76327350 |
94 | MP0001664_abnormal_digestion | 0.75621974 |
95 | * MP0010630_abnormal_cardiac_muscle | 0.75610866 |
96 | MP0005551_abnormal_eye_electrophysiolog | 0.74649377 |
97 | MP0010386_abnormal_urinary_bladder | 0.73393893 |
98 | MP0002069_abnormal_eating/drinking_beha | 0.72869413 |
99 | MP0000631_abnormal_neuroendocrine_gland | 0.67790099 |
100 | MP0006036_abnormal_mitochondrial_physio | 0.66296178 |
101 | MP0004084_abnormal_cardiac_muscle | 0.66006787 |
102 | MP0008775_abnormal_heart_ventricle | 0.65136634 |
103 | MP0004742_abnormal_vestibular_system | 0.64375972 |
104 | MP0005535_abnormal_body_temperature | 0.64367467 |
105 | MP0005451_abnormal_body_composition | 0.64011376 |
106 | MP0005409_darkened_coat_color | 0.63498954 |
107 | MP0002229_neurodegeneration | 0.63402502 |
108 | MP0002106_abnormal_muscle_physiology | 0.63135522 |
109 | MP0006138_congestive_heart_failure | 0.62673853 |
110 | MP0005645_abnormal_hypothalamus_physiol | 0.62646374 |
111 | MP0000465_gastrointestinal_hemorrhage | 0.62271571 |
112 | MP0004134_abnormal_chest_morphology | 0.62206130 |
113 | MP0003075_altered_response_to | 0.61991889 |
114 | MP0003221_abnormal_cardiomyocyte_apopto | 0.61465322 |
115 | MP0005166_decreased_susceptibility_to | 0.59131088 |
116 | MP0004858_abnormal_nervous_system | 0.58681662 |
117 | MP0000747_muscle_weakness | 0.58432272 |
118 | MP0004147_increased_porphyrin_level | 0.58092897 |
119 | MP0004043_abnormal_pH_regulation | 0.57557842 |
120 | MP0005187_abnormal_penis_morphology | 0.56533796 |
121 | MP0000681_abnormal_thyroid_gland | 0.55975013 |
122 | MP0005369_muscle_phenotype | 0.55943966 |
123 | * MP0002972_abnormal_cardiac_muscle | 0.55269613 |
124 | MP0001177_atelectasis | 0.53367108 |
125 | * MP0001943_abnormal_respiration | 0.52097972 |
126 | * MP0010770_preweaning_lethality | 0.49604441 |
127 | * MP0002082_postnatal_lethality | 0.49604441 |
128 | MP0003956_abnormal_body_size | 0.49544351 |
129 | * MP0010769_abnormal_survival | 0.48434482 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Focal motor seizures (HP:0011153) | 9.43306330 |
2 | Hyperventilation (HP:0002883) | 7.04654354 |
3 | Atonic seizures (HP:0010819) | 6.36516125 |
4 | * Epileptic encephalopathy (HP:0200134) | 6.23694078 |
5 | Distal arthrogryposis (HP:0005684) | 5.78136173 |
6 | Febrile seizures (HP:0002373) | 5.74478911 |
7 | Focal seizures (HP:0007359) | 5.73929674 |
8 | Broad-based gait (HP:0002136) | 5.34447837 |
9 | Exercise-induced muscle cramps (HP:0003710) | 5.34182446 |
10 | Type 1 muscle fiber predominance (HP:0003803) | 5.06462175 |
11 | Absence seizures (HP:0002121) | 4.80187060 |
12 | Dialeptic seizures (HP:0011146) | 4.45450240 |
13 | Visual hallucinations (HP:0002367) | 4.34508107 |
14 | Protruding tongue (HP:0010808) | 4.29958902 |
15 | Round ear (HP:0100830) | 4.29756303 |
16 | Sudden death (HP:0001699) | 4.24340344 |
17 | Hyporeflexia of lower limbs (HP:0002600) | 4.09846731 |
18 | Myokymia (HP:0002411) | 4.03238124 |
19 | Subaortic stenosis (HP:0001682) | 3.86569387 |
20 | Abnormality of the left ventricular outflow tract (HP:0011103) | 3.86569387 |
21 | Generalized tonic-clonic seizures (HP:0002069) | 3.84015814 |
22 | Gaze-evoked nystagmus (HP:0000640) | 3.75829212 |
23 | EMG: myopathic abnormalities (HP:0003458) | 3.66337048 |
24 | Ulnar deviation of the wrist (HP:0003049) | 3.56909456 |
25 | Muscle fiber splitting (HP:0003555) | 3.45496891 |
26 | Neck muscle weakness (HP:0000467) | 3.43441330 |
27 | Amblyopia (HP:0000646) | 3.38790320 |
28 | Difficulty running (HP:0009046) | 3.33441193 |
29 | Excessive salivation (HP:0003781) | 3.30284896 |
30 | Drooling (HP:0002307) | 3.30284896 |
31 | Myopathic facies (HP:0002058) | 3.29003815 |
32 | Progressive cerebellar ataxia (HP:0002073) | 3.24426615 |
33 | Fetal akinesia sequence (HP:0001989) | 3.18328525 |
34 | Malignant hyperthermia (HP:0002047) | 3.15265426 |
35 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 3.08209242 |
36 | Dysmetric saccades (HP:0000641) | 3.05877225 |
37 | Absent phalangeal crease (HP:0006109) | 3.04465902 |
38 | Impaired vibration sensation in the lower limbs (HP:0002166) | 2.94290957 |
39 | Absent speech (HP:0001344) | 2.91920558 |
40 | Rimmed vacuoles (HP:0003805) | 2.85178954 |
41 | Epileptiform EEG discharges (HP:0011182) | 2.85067232 |
42 | Urinary bladder sphincter dysfunction (HP:0002839) | 2.83985663 |
43 | Calcaneovalgus deformity (HP:0001848) | 2.83708965 |
44 | * Poor eye contact (HP:0000817) | 2.81453991 |
45 | Bundle branch block (HP:0011710) | 2.76423904 |
46 | Papilledema (HP:0001085) | 2.74079315 |
47 | EMG: neuropathic changes (HP:0003445) | 2.71442283 |
48 | Generalized hypopigmentation of hair (HP:0011358) | 2.69887594 |
49 | Muscle stiffness (HP:0003552) | 2.69544231 |
50 | Frequent falls (HP:0002359) | 2.68997974 |
51 | Impaired smooth pursuit (HP:0007772) | 2.68943602 |
52 | Asymmetric septal hypertrophy (HP:0001670) | 2.68515560 |
53 | Rhabdomyolysis (HP:0003201) | 2.67535128 |
54 | Truncal ataxia (HP:0002078) | 2.66079686 |
55 | Fair hair (HP:0002286) | 2.65775302 |
56 | Gowers sign (HP:0003391) | 2.65009997 |
57 | Abnormal eating behavior (HP:0100738) | 2.64239037 |
58 | Inappropriate behavior (HP:0000719) | 2.62029137 |
59 | Abnormality of skeletal muscle fiber size (HP:0012084) | 2.61774308 |
60 | Abnormal finger flexion creases (HP:0006143) | 2.61358190 |
61 | Type 2 muscle fiber atrophy (HP:0003554) | 2.60408634 |
62 | Myoglobinuria (HP:0002913) | 2.60258750 |
63 | Abnormal hair whorl (HP:0010721) | 2.59679937 |
64 | Exercise-induced myalgia (HP:0003738) | 2.58628448 |
65 | Action tremor (HP:0002345) | 2.56948405 |
66 | Areflexia of lower limbs (HP:0002522) | 2.56282411 |
67 | Weak cry (HP:0001612) | 2.55761728 |
68 | Progressive inability to walk (HP:0002505) | 2.55187571 |
69 | Popliteal pterygium (HP:0009756) | 2.51260320 |
70 | Blue irides (HP:0000635) | 2.49214636 |
71 | Dysdiadochokinesis (HP:0002075) | 2.49057022 |
72 | Fatigable weakness (HP:0003473) | 2.48998468 |
73 | Abnormality of the neuromuscular junction (HP:0003398) | 2.48998468 |
74 | Prolonged QT interval (HP:0001657) | 2.48961783 |
75 | Distal lower limb muscle weakness (HP:0009053) | 2.46302994 |
76 | Muscle hypertrophy of the lower extremities (HP:0008968) | 2.44234035 |
77 | Deformed tarsal bones (HP:0008119) | 2.43828765 |
78 | EEG with generalized epileptiform discharges (HP:0011198) | 2.42618700 |
79 | Polyphagia (HP:0002591) | 2.41603964 |
80 | Hyperthyroidism (HP:0000836) | 2.38814231 |
81 | * Inability to walk (HP:0002540) | 2.35724905 |
82 | Depression (HP:0000716) | 2.34279252 |
83 | Insidious onset (HP:0003587) | 2.29599492 |
84 | Termporal pattern (HP:0011008) | 2.29599492 |
85 | Gait imbalance (HP:0002141) | 2.28428743 |
86 | Impaired vibratory sensation (HP:0002495) | 2.27748871 |
87 | Diplopia (HP:0000651) | 2.27148875 |
88 | Abnormality of binocular vision (HP:0011514) | 2.27148875 |
89 | Mutism (HP:0002300) | 2.27132750 |
90 | Increased variability in muscle fiber diameter (HP:0003557) | 2.26518750 |
91 | * Impaired social interactions (HP:0000735) | 2.26099169 |
92 | * Abnormal social behavior (HP:0012433) | 2.26099169 |
93 | Genetic anticipation (HP:0003743) | 2.25763958 |
94 | Abnormality of salivation (HP:0100755) | 2.23919981 |
95 | Lower limb amyotrophy (HP:0007210) | 2.23099681 |
96 | Status epilepticus (HP:0002133) | 2.21517726 |
97 | * Stereotypic behavior (HP:0000733) | 2.21043360 |
98 | Akinesia (HP:0002304) | 2.20699836 |
99 | Calf muscle hypertrophy (HP:0008981) | 2.20677343 |
100 | Muscle fiber atrophy (HP:0100295) | 2.18978870 |
101 | Scanning speech (HP:0002168) | 2.18834326 |
102 | Lower limb muscle weakness (HP:0007340) | 2.18786445 |
103 | Hypsarrhythmia (HP:0002521) | 2.17239058 |
104 | Abnormality of ocular smooth pursuit (HP:0000617) | 2.15802723 |
105 | Nonprogressive disorder (HP:0003680) | 2.12320274 |
106 | Syncope (HP:0001279) | 2.12176379 |
107 | Thyroid-stimulating hormone excess (HP:0002925) | 2.11024369 |
108 | Myotonia (HP:0002486) | 2.10901826 |
109 | Urinary urgency (HP:0000012) | 2.10740199 |
110 | Abnormal EKG (HP:0003115) | 2.07718006 |
111 | Ankle clonus (HP:0011448) | 2.06384846 |
112 | Hemiplegia (HP:0002301) | 2.05712246 |
113 | Generalized myoclonic seizures (HP:0002123) | 2.04710856 |
114 | Anxiety (HP:0000739) | 2.04626314 |
115 | Bradykinesia (HP:0002067) | 2.01161161 |
116 | Bulbar palsy (HP:0001283) | 2.00829959 |
117 | Exotropia (HP:0000577) | 1.99598756 |
118 | Long clavicles (HP:0000890) | 1.98605786 |
119 | Dysmetria (HP:0001310) | 1.98022022 |
120 | Postural instability (HP:0002172) | 1.96680619 |
121 | Obstructive sleep apnea (HP:0002870) | 1.96435721 |
122 | Generalized muscle weakness (HP:0003324) | 1.95829341 |
123 | Abnormality of the calf musculature (HP:0001430) | 1.94576270 |
124 | Widely spaced teeth (HP:0000687) | 1.94481971 |
125 | Increased connective tissue (HP:0009025) | 1.93944352 |
126 | Shoulder girdle muscle weakness (HP:0003547) | 1.93068330 |
127 | Amniotic constriction ring (HP:0009775) | 1.92222347 |
128 | Abnormality of placental membranes (HP:0011409) | 1.92222347 |
129 | Incomplete penetrance (HP:0003829) | 1.90204752 |
130 | Gastroesophageal reflux (HP:0002020) | 1.89924209 |
131 | Hip contracture (HP:0003273) | 1.88195147 |
132 | Muscle fiber inclusion bodies (HP:0100299) | 1.87420865 |
133 | Abnormality of the lower motor neuron (HP:0002366) | 1.87297024 |
134 | Heart block (HP:0012722) | 1.86746874 |
135 | Spastic gait (HP:0002064) | 1.85070101 |
136 | Medial flaring of the eyebrow (HP:0010747) | 1.83644699 |
137 | Progressive microcephaly (HP:0000253) | 1.81701096 |
138 | Steppage gait (HP:0003376) | 1.81699111 |
139 | Aplasia/Hypoplasia of the brainstem (HP:0007362) | 1.81281110 |
140 | Hypoplasia of the brainstem (HP:0002365) | 1.81281110 |
141 | Pheochromocytoma (HP:0002666) | 1.79022592 |
142 | Sleep apnea (HP:0010535) | 1.78767167 |
143 | Resting tremor (HP:0002322) | 1.78679877 |
144 | Congenital primary aphakia (HP:0007707) | 1.78337984 |
145 | Facial diplegia (HP:0001349) | 1.78139915 |
146 | Hemiparesis (HP:0001269) | 1.77920345 |
147 | Atrial fibrillation (HP:0005110) | 1.77413132 |
148 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 1.77313354 |
149 | Primary atrial arrhythmia (HP:0001692) | 1.77165653 |
150 | Nemaline bodies (HP:0003798) | 1.77117040 |
151 | Distal lower limb amyotrophy (HP:0008944) | 1.76322455 |
152 | Abnormality of alanine metabolism (HP:0010916) | 1.76274955 |
153 | Hyperalaninemia (HP:0003348) | 1.76274955 |
154 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 1.76274955 |
155 | * Intellectual disability, severe (HP:0010864) | 1.75443953 |
156 | Nephrogenic diabetes insipidus (HP:0009806) | 1.75356995 |
157 | Abnormality of the corticospinal tract (HP:0002492) | 1.75104650 |
158 | Gait ataxia (HP:0002066) | 1.74135044 |
Rank | Gene Set | Z-score |
---|---|---|
1 | CASK | 6.91430315 |
2 | EPHA4 | 3.83322599 |
3 | DAPK2 | 3.74466436 |
4 | CDK19 | 3.46863029 |
5 | MAP2K7 | 3.29129662 |
6 | NTRK3 | 3.10887342 |
7 | MAP3K4 | 2.94966494 |
8 | MAP3K12 | 2.86203763 |
9 | MARK1 | 2.79762619 |
10 | DAPK1 | 2.77248987 |
11 | PLK2 | 2.51631388 |
12 | MAP3K9 | 2.42708223 |
13 | RIPK4 | 2.11191726 |
14 | PIK3CG | 2.03888384 |
15 | PINK1 | 1.98424260 |
16 | MAP2K4 | 1.96980755 |
17 | CAMKK2 | 1.75259973 |
18 | MINK1 | 1.75150453 |
19 | PRPF4B | 1.74080723 |
20 | AKT3 | 1.64965483 |
21 | CAMKK1 | 1.45540012 |
22 | MAPK13 | 1.43247460 |
23 | OXSR1 | 1.42733913 |
24 | TNIK | 1.38876740 |
25 | TTN | 1.35072577 |
26 | PAK6 | 1.32569850 |
27 | KSR1 | 1.22035743 |
28 | FRK | 1.21116126 |
29 | SIK2 | 1.20910422 |
30 | SGK2 | 1.19899555 |
31 | CDK5 | 1.19056140 |
32 | SIK3 | 1.16405606 |
33 | PKN1 | 1.16089407 |
34 | NTRK2 | 1.13951187 |
35 | TSSK6 | 1.07339983 |
36 | GRK5 | 1.02683513 |
37 | EPHA3 | 1.00792409 |
38 | PRKCG | 0.98282261 |
39 | FES | 0.96551807 |
40 | DMPK | 0.95143694 |
41 | TIE1 | 0.94319980 |
42 | OBSCN | 0.94029535 |
43 | PDK3 | 0.90865846 |
44 | PDK4 | 0.90865846 |
45 | PTK2B | 0.90519460 |
46 | BMPR2 | 0.86123467 |
47 | PHKG2 | 0.85578810 |
48 | PHKG1 | 0.85578810 |
49 | PIK3CA | 0.84559173 |
50 | SGK494 | 0.83559422 |
51 | SGK223 | 0.83559422 |
52 | CAMK2A | 0.83237610 |
53 | CAMK1 | 0.83184774 |
54 | KSR2 | 0.80413501 |
55 | DAPK3 | 0.78816461 |
56 | CDK18 | 0.78355654 |
57 | SGK3 | 0.76254432 |
58 | PRKD3 | 0.75908254 |
59 | MUSK | 0.73830944 |
60 | MAP3K6 | 0.73400230 |
61 | CDK15 | 0.71195695 |
62 | SGK1 | 0.69852250 |
63 | RAF1 | 0.68852919 |
64 | STK11 | 0.66528543 |
65 | CAMK2G | 0.65452778 |
66 | PDK1 | 0.65046781 |
67 | CDK3 | 0.62523224 |
68 | CDK14 | 0.62363178 |
69 | CDK11A | 0.61782282 |
70 | LATS2 | 0.60809009 |
71 | SYK | 0.59105187 |
72 | MAPKAPK5 | 0.58109413 |
73 | MAP3K13 | 0.55669781 |
74 | PRKCE | 0.55168495 |
75 | PDK2 | 0.54578415 |
76 | CAMK2B | 0.53940396 |
77 | ARAF | 0.53697829 |
78 | MAPK10 | 0.52652502 |
79 | MYLK | 0.52390787 |
80 | NME1 | 0.52102692 |
81 | * MAPK4 | 0.51286414 |
82 | PNCK | 0.50295711 |
83 | MAP3K10 | 0.49848634 |
84 | DYRK1A | 0.48643409 |
85 | PDPK1 | 0.48591878 |
86 | CAMK4 | 0.48348428 |
87 | CDK8 | 0.47139576 |
88 | BLK | 0.46546281 |
89 | TAOK1 | 0.45722910 |
90 | PAK3 | 0.45639966 |
91 | ADRBK2 | 0.45178378 |
92 | MAP2K6 | 0.44463585 |
93 | BRAF | 0.44309613 |
94 | ROCK1 | 0.43392024 |
95 | TEC | 0.41411594 |
96 | WNK3 | 0.41337683 |
97 | PRKCQ | 0.41064064 |
98 | UHMK1 | 0.40947402 |
99 | NTRK1 | 0.40893653 |
100 | PRKACB | 0.40069991 |
101 | CSNK1G2 | 0.39609255 |
102 | MOS | 0.38766591 |
103 | RET | 0.36997478 |
104 | PRKCZ | 0.36336865 |
105 | TAOK2 | 0.35756234 |
106 | PRKCH | 0.35412655 |
107 | * PRKACA | 0.34722465 |
108 | TNK2 | 0.34479708 |
109 | CAMK2D | 0.34470291 |
110 | JAK2 | 0.33751379 |
111 | CSF1R | 0.33647855 |
112 | ADRBK1 | 0.33493907 |
113 | MAP3K7 | 0.33041167 |
114 | MAPKAPK3 | 0.32363650 |
115 | CSNK1D | 0.32354053 |
116 | NEK1 | 0.31676232 |
117 | KIT | 0.31448491 |
118 | JAK1 | 0.30862842 |
119 | TRPM7 | 0.30303306 |
120 | PRKG1 | 0.29581100 |
121 | PRKCB | 0.29399916 |
122 | ERBB3 | 0.27159320 |
123 | ROCK2 | 0.26887813 |
124 | MAP2K1 | 0.26868521 |
125 | FYN | 0.26158339 |
126 | MAP3K2 | 0.25904425 |
127 | * RPS6KA3 | 0.25301393 |
128 | MARK2 | 0.25294682 |
129 | FGR | 0.24715065 |
130 | * MAPK12 | 0.24325282 |
131 | GRK6 | 0.24206500 |
132 | MAP3K5 | 0.22913535 |
133 | GRK7 | 0.20401088 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Nicotine addiction_Homo sapiens_hsa05033 | 3.87760555 |
2 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 3.69019370 |
3 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 2.87924411 |
4 | Circadian entrainment_Homo sapiens_hsa04713 | 2.80882960 |
5 | Long-term potentiation_Homo sapiens_hsa04720 | 2.78659546 |
6 | Olfactory transduction_Homo sapiens_hsa04740 | 2.66841346 |
7 | Morphine addiction_Homo sapiens_hsa05032 | 2.60816204 |
8 | Amphetamine addiction_Homo sapiens_hsa05031 | 2.46103449 |
9 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 2.37591175 |
10 | Glutamatergic synapse_Homo sapiens_hsa04724 | 2.36917196 |
11 | GABAergic synapse_Homo sapiens_hsa04727 | 2.35690681 |
12 | Salivary secretion_Homo sapiens_hsa04970 | 2.14923659 |
13 | Renin secretion_Homo sapiens_hsa04924 | 2.06185785 |
14 | Dopaminergic synapse_Homo sapiens_hsa04728 | 2.04528938 |
15 | * Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.87726936 |
16 | Insulin secretion_Homo sapiens_hsa04911 | 1.84095889 |
17 | Long-term depression_Homo sapiens_hsa04730 | 1.77736335 |
18 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.74288590 |
19 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.72690754 |
20 | Taste transduction_Homo sapiens_hsa04742 | 1.72278264 |
21 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.69518922 |
22 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.69146052 |
23 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.65179362 |
24 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.61091701 |
25 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 1.46025933 |
26 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.45248376 |
27 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 1.34443629 |
28 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 1.33480734 |
29 | GnRH signaling pathway_Homo sapiens_hsa04912 | 1.27284928 |
30 | Gap junction_Homo sapiens_hsa04540 | 1.24830884 |
31 | cAMP signaling pathway_Homo sapiens_hsa04024 | 1.22323523 |
32 | Asthma_Homo sapiens_hsa05310 | 1.17706779 |
33 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 1.16475943 |
34 | * cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 1.14612900 |
35 | Cocaine addiction_Homo sapiens_hsa05030 | 1.14452163 |
36 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 1.12331162 |
37 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.09426430 |
38 | Glioma_Homo sapiens_hsa05214 | 1.09153464 |
39 | ErbB signaling pathway_Homo sapiens_hsa04012 | 1.08563787 |
40 | Phototransduction_Homo sapiens_hsa04744 | 1.07932565 |
41 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 1.07792233 |
42 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.07659561 |
43 | Axon guidance_Homo sapiens_hsa04360 | 1.05885335 |
44 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 1.03068439 |
45 | Viral myocarditis_Homo sapiens_hsa05416 | 1.00986576 |
46 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.99208218 |
47 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.98702240 |
48 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.98171423 |
49 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.92473742 |
50 | Circadian rhythm_Homo sapiens_hsa04710 | 0.91717478 |
51 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.91619556 |
52 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.91009682 |
53 | * MAPK signaling pathway_Homo sapiens_hsa04010 | 0.85360609 |
54 | Allograft rejection_Homo sapiens_hsa05330 | 0.84050505 |
55 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.83656850 |
56 | Melanogenesis_Homo sapiens_hsa04916 | 0.82836863 |
57 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.80427069 |
58 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.74962315 |
59 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.73345779 |
60 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.72674333 |
61 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.71073389 |
62 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.70700568 |
63 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.70442936 |
64 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.70376829 |
65 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.69523574 |
66 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.69198466 |
67 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.68264529 |
68 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.68010098 |
69 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.66775134 |
70 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.66015370 |
71 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.65965886 |
72 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.65356605 |
73 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.64180358 |
74 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.63277916 |
75 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.63238925 |
76 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.62188108 |
77 | Alzheimers disease_Homo sapiens_hsa05010 | 0.61238604 |
78 | Platelet activation_Homo sapiens_hsa04611 | 0.59635452 |
79 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.59314729 |
80 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.57087821 |
81 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.56628379 |
82 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.53850846 |
83 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.53600517 |
84 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.52655219 |
85 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.52267704 |
86 | Leishmaniasis_Homo sapiens_hsa05140 | 0.51025688 |
87 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.50826108 |
88 | Phagosome_Homo sapiens_hsa04145 | 0.50203479 |
89 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.47664973 |
90 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.47218910 |
91 | Colorectal cancer_Homo sapiens_hsa05210 | 0.46789523 |
92 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.46708433 |
93 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.46431456 |
94 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.44574671 |
95 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.44495202 |
96 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.44459131 |
97 | Focal adhesion_Homo sapiens_hsa04510 | 0.44062329 |
98 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.42544739 |
99 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.42018682 |
100 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.41550014 |
101 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.40943266 |
102 | Alcoholism_Homo sapiens_hsa05034 | 0.40912694 |
103 | Wnt signaling pathway_Homo sapiens_hsa04310 | 0.40027726 |
104 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.39791326 |
105 | Insulin resistance_Homo sapiens_hsa04931 | 0.39592641 |
106 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.39272401 |
107 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.39206896 |
108 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.39047122 |
109 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.38951466 |
110 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.38353916 |
111 | Endometrial cancer_Homo sapiens_hsa05213 | 0.38155932 |
112 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.37607488 |
113 | Tuberculosis_Homo sapiens_hsa05152 | 0.37182219 |
114 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.36450497 |
115 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.35237735 |
116 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.35163536 |
117 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.34439954 |
118 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.34327623 |
119 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.33990997 |
120 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.33789893 |
121 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.33523175 |
122 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.32465996 |